Linked Data API

Show Search Form

Search Results

433889
registered interest false more like this
date less than 2015-11-30more like thismore than 2015-11-30
answering body
Department for Culture, Media and Sport more like this
answering dept id 10 more like this
answering dept short name Culture, Media and Sport more like this
answering dept sort name Culture, Media and Sport more like this
hansard heading Cultural Heritage more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Culture, Media and Sport, what steps his Department is taking to help protect heritage sites worldwide. more like this
tabling member constituency Chelmsford remove filter
tabling member printed
Sir Simon Burns more like this
uin 902547 more like this
answer
answer
is ministerial correction false more like this
date of answer remove maximum value filtermore like thismore than 2015-12-03
answer text <p>The protection of cultural heritage affected by acts of destruction is a priority for this Government. We are committing £30 million towards a new Cultural Protection Fund and will bring forward legislation to enable the UK to ratify the 1954 Hague Convention for the Protection of Cultural Property in the Event of Armed Conflict and its two Protocols at the first opportunity.</p> more like this
answering member constituency Wantage more like this
answering member printed Mr Edward Vaizey more like this
question first answered
less than 2015-12-03T15:17:29.347Zmore like thismore than 2015-12-03T15:17:29.347Z
answering member
1580
label Biography information for Lord Vaizey of Didcot more like this
tabling member
46
label Biography information for Sir Simon Burns more like this
348536
registered interest false more like this
date less than 2015-06-04more like thismore than 2015-06-04
answering body
Ministry of Justice more like this
answering dept id 54 more like this
answering dept short name Justice more like this
answering dept sort name Justice more like this
hansard heading HM Courts and Tribunals Service more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Justice, when he expects HM Courts and Tribunals Service to send to the Department for Work and Pensions the Statement of Reasons in respect of the recent appeal, Ref: SC133/14/00156, relating to Ms C Ely; and if he will make a statement. more like this
tabling member constituency Chelmsford remove filter
tabling member printed
Mr Simon Burns more like this
uin 1254 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-06-09more like thismore than 2015-06-09
answer text <p /> <p>The First-tier Tribunal - Social Security and Child Support, administered by HM Courts &amp; Tribunals Service hears appeals against Department for Work and Pensions’ (DWP) decisions on a range of benefits.</p><p> </p><p>The Tribunal heard the appeal brought by Ms Ely on 27 April. A request for a full statement of reasons was received from the DWP on 15 May.</p><p> </p><p>The Tribunal’s Procedure Rules require the statement of reasons to be provided within one month of the request or as soon as practicable thereafter.</p> more like this
answering member constituency North West Cambridgeshire more like this
answering member printed Mr Shailesh Vara more like this
question first answered
less than 2015-06-09T16:22:00.563Zmore like thismore than 2015-06-09T16:22:00.563Z
answering member
1496
label Biography information for Shailesh Vara more like this
tabling member
46
label Biography information for Sir Simon Burns more like this
227534
registered interest false more like this
date less than 2015-03-16more like thismore than 2015-03-16
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading HIV Infection more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many finished consultant episodes there were with a (a) primary and (b) secondary diagnosis of HIV infection in (i) England and (ii) each region in each year since 1989. more like this
tabling member constituency Chelmsford remove filter
tabling member printed
Mr Simon Burns more like this
uin 227661 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-19more like thismore than 2015-03-19
answer text <p>Available data is set out in the attached table. This includes data for England from 1998 and regional data from 2003.</p><p> </p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-03-19T15:37:15.913Zmore like thismore than 2015-03-19T15:37:15.913Z
answering member
3918
label Biography information for Jane Ellison more like this
attachment
1
file name FCEs- Primary & Secondary diagnosis HIV 1998-03.xlsx more like this
title FCEs- primary & secondary diagnosis of HIV 1998-03 more like this
tabling member
46
label Biography information for Sir Simon Burns more like this
227535
registered interest false more like this
date less than 2015-03-16more like thismore than 2015-03-16
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading HIV Infection more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what steps he is taking to develop the understanding, prevention, diagnosis and treatment of HIV among NHS clinicians who do not specialise in HIV; what assessment he has made of the adequacy and extent of training on HIV for such clinicians; and if he will make a statement. more like this
tabling member constituency Chelmsford remove filter
tabling member printed
Mr Simon Burns more like this
uin 227662 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-19more like thismore than 2015-03-19
answer text <p>Health Education England has developed a number of e-learning sessions on Sexual Health and HIV across programmes designed for foundation trainees, general practitioners, dentists, radiologists as well as specialists. The programmes cover topics such as HIV testing, the importance of early diagnosis and Oral Manifestations of HIV and AIDS. The content for these programmes is available to all National Health Service employees irrespective of their speciality and includes e-learning resources.</p><p> </p><p><strong> </strong></p><p> </p><p>The Department has funded the Medical Foundation for AIDS and Sexual Health to produce resources to support non-specialist clinicians in primary and secondary care services to offer HIV testing to help reduce late diagnosis of HIV. This includes <em>HIV Testing in Practice</em>, an interactive web-based resource for primary care which went live in November 2014.</p><p> </p><p> </p><p> </p><p>NHS England commission HIV treatment and care services in-line with a detailed service specification. Non-specialist clinical services, including primary care might be able to deliver parts of the care pathway in discussion with specialist HIV care providers.</p><p> </p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-03-19T15:15:40.417Zmore like thismore than 2015-03-19T15:15:40.417Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
46
label Biography information for Sir Simon Burns more like this
177524
registered interest false more like this
date less than 2015-02-03more like thismore than 2015-02-03
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading HIV Infection more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, with reference to Public Health England's report on HIV in the UK, published in November 2014, what the evidential basis was of the conclusions in the report; from what sources that data was derived; how frequently such data is published; and when data equivalent to that data will next be published. more like this
tabling member constituency Chelmsford remove filter
tabling member printed
Mr Simon Burns more like this
uin 223027 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-02-09more like thismore than 2015-02-09
answer text <p>Public Health England (PHE) undertakes surveillance of the number of people newly diagnosed with human immunodeficiency virus (HIV), the number of people living with diagnosed HIV infection, and the clinical outcomes of HIV infection, including acquired immune deficiency syndrome (AIDS) and deaths. These data relate to the adults in England, Wales and Northern Ireland. Scottish data (Health Protection Scotland) and paediatric data (Institute of Child Health) are collected separately and collated to produce the national surveillance tables.</p><p> </p><p> </p><p> </p><p>“HIV in the United Kingdom” is a report released annually by PHE in time for World AIDS Day (1 December). The report describes the HIV epidemic in the United Kingdom to date, including trends in new diagnoses and new infections, HIV prevalence, clinical outcomes for people living with HIV and behavioural and HIV testing trends. The data directly inform and evaluate the public health response to the HIV epidemic.</p><p> </p><p> </p><p> </p><p>The conclusions of the report are developed by public health professionals who co-ordinate HIV surveillance activities, and are reached through interpretation of the HIV surveillance data.</p><p> </p><p> </p><p> </p><p>Data sources, frequency of published data and date of next publication are available in the attached annex.</p><p> </p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-02-09T17:07:15.473Zmore like thismore than 2015-02-09T17:07:15.473Z
answering member
3918
label Biography information for Jane Ellison more like this
attachment
1
file name Annex to PQ223027.doc more like this
title Data frequency/sources& next publication date info more like this
tabling member
46
label Biography information for Sir Simon Burns more like this
177525
registered interest false more like this
date less than 2015-02-03more like thismore than 2015-02-03
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading HIV Infection more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what data is used to inform the quality dashboard programme developed by NHS England to monitor the quality of HIV care; from what sources that data was derived; how frequently such data is published; and when equivalent data will next be published. more like this
tabling member constituency Chelmsford remove filter
tabling member printed
Mr Simon Burns more like this
uin 223028 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-02-09more like thismore than 2015-02-09
answer text <p>The data for the human immunodeficiency virus (HIV) quality dashboard are provided by Public Health England (PHE) using the national HIV surveillance and monitoring system which uses data directly submitted to PHE by HIV service providers. PHE uses the data to inform clinically important metrics of the quality of HIV care. These include late HIV diagnosis, time from HIV diagnosis to entry into HIV care, retention in HIV care and effectiveness of HIV treatment and care.</p><p> </p><p> </p><p> </p><p>In 2015, the annual national dashboard information will be published in the autumn (data to the end 2014); trust level information (to end 2013) will be circulated (not published) to trusts and commissioners in June 2015.</p><p> </p><p> </p><p> </p><p>Trust level data are used to monitor the quality of care and outcomes of HIV services to drive service improvement. The dashboard metrics are published online at:</p><p> </p><p> </p><p> </p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/npc-crg/spec-dashboards/" target="_blank">https://www.england.nhs.uk/commissioning/spec-services/npc-crg/spec-dashboards/</a></p><p> </p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-02-09T17:35:02.487Zmore like thismore than 2015-02-09T17:35:02.487Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
46
label Biography information for Sir Simon Burns more like this
177173
registered interest false more like this
date less than 2015-02-02more like thismore than 2015-02-02
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading HIV Infection more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many outpatient and inpatient appointments were (a) emergency and (b) elective with a (i) primary and (ii) secondary diagnosis of HIV in (A) England and (B) each clincial commissioning group area in each of the last 12 months; and what the average waiting time was for each such appointment. more like this
tabling member constituency Chelmsford remove filter
tabling member printed
Mr Simon Burns more like this
uin 222963 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-02-05more like thismore than 2015-02-05
answer text <p>The available information is set out in the attachments from Public Health England and the Health and Social Care Information Centre.</p><p> </p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
attachment
1
file name PQ222963 Public Health England.docx more like this
title PHE - HIV diagnosis (1) England (2) CCGs more like this
2
file name PQ222963 HSCIC Table.xlsx more like this
title Finished Admission Episodes by CCGs more like this
question first answered
less than 2015-02-05T17:47:38.157Zmore like thismore than 2015-02-05T17:47:38.157Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
46
label Biography information for Sir Simon Burns more like this
177202
registered interest false more like this
date less than 2015-02-02more like thismore than 2015-02-02
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading HIV Infection more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, when his Department next plans to publish data derived from the HIV and AIDS reporting system (HARS); what data from HARS will be made available publicly and at what frequency; and if he will make a statement. more like this
tabling member constituency Chelmsford remove filter
tabling member printed
Mr Simon Burns more like this
uin 222915 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-02-05more like thismore than 2015-02-05
answer text <p>The human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) Reporting System (HARS) is a new, integrated reporting system for information on adults living with diagnosed HIV infection in England. It will be designated as an Official Statistic. A full data set from HARS is not yet available. HARS data relating to 2015 will be available in the summer of 2016 and published on an annual basis thereafter to inform and evaluate the public health response to HIV. The publication of the HARS data HARS data to inform commissioning will be made available to commissioners on a quarterly basis.</p><p> </p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-02-05T17:33:28.75Zmore like thismore than 2015-02-05T17:33:28.75Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
46
label Biography information for Sir Simon Burns more like this
175109
registered interest false more like this
date less than 2015-01-21more like thismore than 2015-01-21
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading NHS: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much the NHS spent on (a) all drugs, (b) cancer drugs and (c) drugs funded through the Cancer Drug Fund in each of the last five years for which figures are available. more like this
tabling member constituency Chelmsford remove filter
tabling member printed
Mr Simon Burns more like this
uin 221615 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-01-29more like thismore than 2015-01-29
answer text <p>Figures provided for Primary Care for total drug spend are the total of net ingredient cost (NIC) and for Secondary Care the cost of the medicines at NHS list price.</p><p> </p><p> </p><p> </p><p> </p><table><tbody><tr><td colspan="6"><p>Cost of drugs in primary and secondary care, England: 2009-10 to 2013-14</p></td></tr><tr><td><p>Total drugs</p></td><td colspan="4"><p> </p></td><td><p>Cost (£ million)</p></td></tr><tr><td><p> </p></td><td colspan="2"><p>Primary Care<sup>1</sup></p></td><td colspan="2"><p>Secondary Care<sup>2</sup></p></td><td><p>Total</p></td></tr><tr><td><p>2009-10</p></td><td colspan="2"><p>8,621.4</p></td><td colspan="2"><p>3,890.8</p></td><td><p>12,512.2</p></td></tr><tr><td><p>2010-11</p></td><td colspan="2"><p>8,881.1</p></td><td colspan="2"><p>4,173.9</p></td><td><p>13,055.0</p></td></tr><tr><td><p>2011-12</p></td><td colspan="2"><p>8,778.0</p></td><td colspan="2"><p>4,497.6</p></td><td><p>13,275.5</p></td></tr><tr><td><p>2012-13</p></td><td colspan="2"><p>8,439.0</p></td><td colspan="2"><p>5,020.8</p></td><td><p>13,459.8</p></td></tr><tr><td><p>2013-14</p></td><td colspan="2"><p>8,703.2</p></td><td colspan="2"><p>5,780.6</p></td><td><p>14,483.8</p></td></tr><tr><td colspan="6"><p><em>Sources:</em> Prescription Cost Analysis (PCA), IMS HEALTH: Hospital Pharmacy Audit</p></td></tr><tr><td colspan="6"><p>Cost of cancer drugs<sup>3 </sup>in primary and secondary care, England: 2009-10 to 2013-14</p></td></tr><tr><td><p>Total drugs</p></td><td colspan="4"><p> </p></td><td><p>Cost (£ million)</p></td></tr><tr><td><p> </p></td><td colspan="2"><p>Primary Care<sup>1,4</sup></p></td><td colspan="2"><p>Secondary Care<sup>2</sup></p></td><td><p>Total</p></td></tr><tr><td><p>2009-10</p></td><td colspan="2"><p>230.2</p></td><td colspan="2"><p>748.1</p></td><td><p>978.3</p></td></tr><tr><td><p>2010-11</p></td><td colspan="2"><p>228.2</p></td><td colspan="2"><p>846.1</p></td><td><p>1,074.3</p></td></tr><tr><td><p>2011-12</p></td><td colspan="2"><p>190.0</p></td><td colspan="2"><p>964.1</p></td><td><p>1,154.1</p></td></tr><tr><td><p>2012-13</p></td><td colspan="2"><p>142.0</p></td><td colspan="2"><p>1,119.6</p></td><td><p>1,261.6</p></td></tr><tr><td><p>2013-14</p></td><td colspan="2"><p>143.0</p></td><td colspan="2"><p>1,350.2</p></td><td><p>1,493.2</p></td></tr><tr><td colspan="6"><p><em>Sources:</em> PCA, IMS HEALTH: Hospital Pharmacy Audit</p></td></tr><tr><td colspan="4"><p>Spend through the Cancer Drugs Fund between October 2010 and March 2014</p></td><td colspan="2"><p> </p></td></tr><tr><td colspan="2"><p>Year</p></td><td colspan="2"><p>Spend (£000’s)</p></td><td colspan="2"><p> </p></td></tr><tr><td colspan="2"><p>2010-11 (Q3 and Q4)</p></td><td colspan="2"><p>38,254</p></td><td colspan="2"><p> </p></td></tr><tr><td colspan="2"><p>2011-12</p></td><td colspan="2"><p>108,327</p></td><td colspan="2"><p> </p></td></tr><tr><td colspan="2"><p>2012-13</p></td><td colspan="2"><p>175,334</p></td><td colspan="2"><p> </p></td></tr><tr><td colspan="2"><p>2013-14</p></td><td colspan="2"><p>230,539</p></td><td colspan="2"><p> </p></td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr></tbody></table><p> </p><p><em>Source:</em> Prior to April 2013, information supplied to the Department by strategic health authorities. From April 2013, information supplied by NHS England.</p><p> </p><p> </p><p> </p><p><em>Notes:</em></p><p> </p><p><sup>1 </sup>Primary Care NIC is the basic cost of the drug, which does not take account of discounts, dispensing costs, fees or prescription charges income.</p><p> </p><p><sup>2 </sup>Secondary care cost is the cost of the medicines at NHS list price which may not reflect the price the hospital paid.</p><p> </p><p><sup>3 </sup>Cancer drugs are defined by British National Formulary Sections 8.1 <em>Cytotoxic drugs</em>,</p><p> </p><p>8.2.3 <em>Anti-lymphocyte monoclonal antibodies</em> (but also used in other indications), 8.2.4 <em>Other immunomodulating drugs</em> (Interferon-Alfa, Aldesleukin, Bacillus Calmette-Guerin (B.C.G.), Lenalidomide, Pomalidomide, Thalidomide and Mifamurtide only), and 8.3 <em>Sex hormones and hormone antagonists in malignant disease</em>.</p><p> </p><p><sup>4 </sup>The main reason for the reduction in cancer drugs in Primary Care is the introduction of lower cost generic formulations.</p><p> </p><p> </p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2015-01-29T10:27:54.12Zmore like thismore than 2015-01-29T10:27:54.12Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
46
label Biography information for Sir Simon Burns more like this
170705
registered interest false more like this
date less than 2014-12-16more like thismore than 2014-12-16
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what medicines the National Institute for Health and Care Excellence (NICE) (a) has evaluated and (b) intends to evaluate using the highly specialised technologies process; and what medicines his Department is planning to refer to NICE for assessment through that process. more like this
tabling member constituency Chelmsford remove filter
tabling member printed
Mr Simon Burns more like this
uin 218948 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-01-05more like thismore than 2015-01-05
answer text <p>The National Institute for Health and Care Excellence (NICE) has been asked to evaluate the following treatments under its highly specialised technologies (HST) programme:</p><p> </p><p> </p><p> </p><table><thead><tr><td><p>Assessment title</p></td><td><p>Anticipated publication date</p></td></tr></thead><tbody><tr><td><p>Atypical haemolytic uraemic syndrome - eculizumab</p></td><td><p>January 2015</p></td></tr><tr><td><p>Gaucher disease (type 1) - eliglustat</p></td><td><p>August 2015</p></td></tr><tr><td><p>Mucopolysaccharidosis (type IVA) - elosulfase alfa</p></td><td><p>October 2015</p></td></tr><tr><td><p>Paediatric-onset hypophosphatasia - asfotase alfa</p></td><td><p>October 2015</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>NICE has not yet issued any final guidance through this programme.</p><p> </p><p> </p><p> </p><p>A number of other medicines are being considered for referral to NICE’s HST programme through the established topic selection arrangements. Information on these is currently commercially confidential and cannot be released at this stage.</p><p> </p><p><br> <br></p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2015-01-05T15:14:44.19Zmore like thismore than 2015-01-05T15:14:44.19Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
46
label Biography information for Sir Simon Burns more like this